Skip to main content
Caplight Logo









Eurofarma Ventures

Eurofarma Ventures

São Pauloeurofarma.com

Overview

Eurofarma Ventures is the corporate venture capital arm of Eurofarma Laboratórios, focusing on early-stage investments in biotech companies in the US and Europe. The fund targets therapeutics and platform companies, with a focus on precision medicine, gene editing, new therapeutic targets, and artificial intelligence applied to molecule discovery.

Year Founded

2023

Portfolio Companies

4

Investments

Eurofarma Ventures investments
CompanyDateStageLead
AbcuroAug 2026Series DCo-investor
PsiTheraDec 2025Series ACo-investor
PsiTheraDec 2025Series ACo-investor
AbcuroFeb 2025Series CCo-investor
ROME TherapeuticsSep 2023Series B Extension-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSão Paulo
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?